Podcast
Scientists may be able to minimize adverse effects while gaining a better understanding of psychedelic medicines' efficacy and durability.
This month, we spoke with Joseph Araujo, co-founder, director, and chief scientific officer at Mindset Pharma, to get an overview of the differences between synthetic and natural psychedelic medicines. By developing synthetic versions of natural medicines, scientists may be able to minimize adverse effects while gaining a better understanding of their efficacy and durability.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.